English | Hindi | Spanish | Deutch

ACS Updates Guidelines Regarding Overlapping Surgeries

ACS Updates Guidelines Regarding Overlapping Surgeries

Practice of one surgeon performing in two surgeries scheduled at the same time, the American College of Surgeons (ACS) has updated its guidelines. [Statements on Principles, revised by ACS April 12.}

1.    ACS advises against concurrent or simultaneous surgeries and defines them as those in which "the critical or key components of the procedures for which the primary attending surgeon is responsible are occurring all or in part at the same time."

2.     A primary attending surgeon's involvement in concurrent or simultaneous surgeries on two different patients in two different rooms is not appropriate.  But overlapping surgeries are different, and may be appropriate. For instance, if key or critical elements of the first operation are finished, freeing up the primary attending to start an operation in another room while others finish the first operation.

3.     As part of the preoperative discussion, patients should be informed of the different types of qualified medical providers that will participate in their surgery (assistant attending surgeon, fellows, resident and interns, physician assistants, nurse practitioners, etc.) and their respective role explained. If an urgent or emergent situation arises that require the surgeon to leave the operating room unexpectedly, the patient should be subsequently informed.

4.     The guidelines are important in clarifying the differences between concurrent, overlapping, multidisciplinary, and sequential operations.

5.     Patients have a right to know these details. Most patients will have few, if any, concerns with overlapping surgeries as long as their surgeon is present for the critical portion of the operation and they are informed, and agree to, the surgeon who will be performing the noncritical portions of their operation.

6.     Surgeons will need to have discussions about what 'critical portion of the operation' means and who might be performing some of the noncritical portions of the operation.

Early ultrasound may miss microcephaly: A case of Zika virus infection (ZIKV) with prolonged viremia in the mother and fast-moving but hard-to-detect brain damage in the fetus may point to new changes in how clinicians should care for pregnant women who have contracted this disease, according to a brief report published online March 30 in theNew England Journal of Medicine.

AF after tAVI: Atrial fibrillation patients getting transcatheter aortic valve replacement carry heavier risks of poor outcomes after the procedure. Pre-existing atrial fibrillation -- present in 36% of patients -- was an independent predictor of mortality at 1 year (hazard ratio 1.55, 95% CI 1.26-1.91, P<0.0001), Giuseppe Tarantini, MD, PhD, of the University Hospital of Padua in Italy, and colleagues reported in JACC: Cardiovascular Interventions.

Bariatric surgery:  has evolved quite a bit over the past decade, and especially in the last few years, for two reasons. The first and fairly obvious reason is the many technological advancements that have occurred, not only in surgical but also in nonsurgical techniques.

British Medical Journal: Pioglitazone causes bladder cancer: The results of this large population based study indicate that pioglitazone is associated with an increased risk of bladder cancer. The absence of an association with rosiglitazone suggests that the increased risk is drug specific and not a class effect.

Healthy diet may reduce high blood pressure after gestational diabetes

Sticking to a healthy diet in the years after pregnancy may reduce the risk of high blood pressure among women who had pregnancy-related (gestational) diabetes, according to a study by researchers at the National Institutes of Health and other institutions. The study was published in Hypertension.

Islet transplantation restores control in type 1 diabetes: New clinical trial results show that transplantation of pancreatic islets — cell clusters that contain insulin-producing cells—prevents severe, potentially life-threatening drops in blood sugar in people with type 1 diabetes. Researchers found that the treatment was effective for people who experienced episodes of severe hypoglycemia — low blood sugar levels that can lead to seizures, loss of consciousness and death — despite receiving expert care.